ODI Pharma AB postpones publication of interim report and annual report until November 24, 2023

ODI Pharma AB (“ODI” or the “Company”) stated in its year-end report that the interim report for the first quarter of 2023/2024 and the annual report for the fiscal year 2022/2023 would be published on November 23, 2023. Instead, the interim report and the annual report will be published on November 24, 2023, three weeks before the Annual General Meeting on December 15, 2023.  

For more information, please contact:

Derek Simmross, CEO, ODI Pharma AB

E-mail: [email protected]